- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT06931743
갑상선 수술의 수술 후 통증 관리에서 전기 자극의 적용
갑상선 수술 후 통증 관리에서 손목 및 발목 전기 자극 진통제 치료 장치의 적용에 관한 연구
Post-thyroidectomy pain is a prevalent early postoperative complication. While pharmacological agents remain the mainstay of analgesia, their clinical application is constrained by adverse effects including nausea, respiratory depression, and gastrointestinal disturbances. Transcutaneous electrical nerve stimulation based on wrist-ankle acupuncture theory (TENS-WAA) is a non-invasive analgesic modality that has demonstrated preliminary benefits in multiple pain scenarios. Nevertheless, robust evidence for its efficacy in post-thyroidectomy pain management is still lacking, limited by single-center designs and small sample sizes in existing studies.
This trial aims to evaluate the efficacy and safety of TENS-WAA for pain control after thyroidectomy. The findings are expected to support a standardized non-pharmacological analgesic option as an adjunct to multimodal postoperative pain regimens, aligning with Enhanced Recovery After Surgery (ERAS) principles.
연구 개요
상세 설명
Background Post-thyroidectomy pain is a prevalent early complication stemming from incision trauma, tissue retraction and cervical muscle spasm, which impairs early functional recovery and reduces patient satisfaction. Opioids and non-steroidal anti-inflammatory drugs remain the mainstay of postoperative analgesia, but their clinical value is limited by suboptimal pain control, well-recognized adverse effects (nausea, respiratory depression, constipation, bleeding and renal risks), and marked inter-individual variability in therapeutic response. Aligned with Enhanced Recovery After Surgery (ERAS) principles, multimodal analgesia integrating pharmacological and non-pharmacological strategies is increasingly recommended. However, no standardized non-pharmacological analgesic protocol exists for post-thyroidectomy pain. Transcutaneous electrical nerve stimulation based on wrist-ankle acupuncture theory (TENS-WAA) is a non-invasive, self-administrable analgesic approach. Preliminary evidence supports its efficacy across multiple pain conditions, potentially via modulating pain-related brain regions and promoting endogenous opioid release. Current evidence in thyroidectomy populations is limited by single-center designs, small samples and protocol heterogeneity, requiring high-quality multicenter randomized controlled trials for validation.
Study Objectives To evaluate the efficacy of TENS-WAA in reducing post-thyroidectomy pain intensity compared with sham stimulation.
Study Design This is a prospective, multicentre, randomised, open-label, assessor-blinded, parallel-group superiority controlled trial, conducted across three tertiary hospitals in China. A total of 668 patients scheduled for elective conventional thyroidectomy will be enrolled. Eligible participants will be stratified by surgery type (unilateral thyroidectomy vs. bilateral thyroidectomy), and randomised in a 1:1 ratio to either the active TENS-WAA group or the sham stimulation group via stratified block randomisation. Random allocation will be implemented through a central web-based randomisation system to ensure allocation concealment. Given the perceptible nature of electrical stimulation, participants and intervention administrators will not be blinded to group assignment. However, outcome assessors responsible for pain scoring, data collection and biosample processing, as well as the study statistician, will remain blinded to group allocation throughout the trial. All primary efficacy analyses will follow the intention-to-treat (ITT) principle. The recruitment period is scheduled from May 2025 to December 2026.
Intervention Description All participants will receive standard postoperative care in accordance with each institution's routine clinical protocols. The study intervention will be delivered at three postoperative time points: immediately upon returning to the ward, and 2 hours and 4 hours after returning to the ward, with each stimulation session lasting 30 minutes.
Primary Outcome Pain intensity measured by the 10-cm Visual Analogue Scale (VAS), where 0 represents "no pain" and 10 represents "the worst pain imaginable". VAS assessments will be conducted at multiple time points: upon awakening from anaesthesia, immediately after each stimulation session, and at 3, 9, 15, and 24 hours after surgery. Longitudinal VAS data will be analysed using generalized estimating equations, adjusted for baseline VAS score, age, sex and surgery type.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: ChaoQian Liu
- 전화번호: 13761030978
- 이메일: aj04022x@foxmail.com
연구 연락처 백업
- 이름: Jin Du
- 전화번호: 18009661988
- 이메일: 1352266146@qq.com
연구 장소
-
-
Changning District
-
Shanghai, Changning District, 중국, 200000
- 모병
- the Specialised Medical Centre of the Chinese People's Liberation Army Navy
-
연락하다:
- Jin Du
- 전화번호: 18009661988
- 이메일: 1352266146@qq.com
-
-
Huangpu District
-
Shanghai, Huangpu District, 중국, 200000
- 모병
- Changzheng Hospital Affiliated to the Naval Medical University
-
연락하다:
- Jin Du
- 전화번호: 18009661988
- 이메일: 1352266146@qq.com
-
-
Yangpu District
-
Shanghai, Yangpu District, 중국, 200000
- 모병
- Changhai Hospital Affiliated to the Naval Medical University
-
연락하다:
- Jin Du
- 전화번호: 18009661988
- 이메일: 1352266146@qq.com
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
-
Inclusion Criteria:
- Be over 18 years of age;
- The operation time is less than 4 hours;
- Postoperative VAS pain score ≥3 points ;
- Clear consciousness, able to answer questions accurately, free speech, no hearing impairment;
- Informed consent
-
Exclusion Criteria:
- Neck or thyroid surgery within the past ten years;
- Menstruating, pregnant and lactating females;Those who are not satisfied with blood glucose control;
- Skin injury or allergy; skin ulceration;
- Past history of psychiatric disorder that met the diagnostic criteria of Diagnostic and Manual of Mental Disorders, DSM-IV;
- Upper respiratory tract infection within 2 weeks before surgery;
- History of implantation of pace or defibrillator;
- Allergic to gel or intolerant to electrical stimulation;
- History of chronic pain, pain VAS score 1 at the examination;
- Use of sedative analgesic drugs for a long time or within 24 hours;
- Particip in other clinical trials in the past 4 weeks.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
가짜 비교기: Sham stimulation group
|
다른 이름들:
(4)30 minutes of ineffective microcurrent stimulation.
다른 이름들:
|
|
실험적: TENS-WAA
|
다른 이름들:
(4)30 minutes of ineffective microcurrent stimulation.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Pain VAS score
기간: Evaluation time: 1) the subject returned to the ward after surgery; 2) immediately after electrical stimulation; 3) Postoperative 2 hours、Postoperative 3 hours、Postoperative 4 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours
|
VAS (Visual Analogue Scale) scoring, namely visual analogue scoring, usually employs a straight line or ruler 10 centimeters long, with0 representing the "no pain end" and 10 representing the "most intense pain". The patient marks on the straight line according to the level of pain he or she, to indicate the intensity of pain and the degree of unpleasant psychological experience. The higher the VAS score, the more painful it is. 0 points: no pain; -3 points: mild pain; 4-6 points: moderate pain; 7-9 severe pain; 10 points: unbearable pain, namely severe pain |
Evaluation time: 1) the subject returned to the ward after surgery; 2) immediately after electrical stimulation; 3) Postoperative 2 hours、Postoperative 3 hours、Postoperative 4 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
PONV classification
기간: Postoperative 3 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours
|
The PONV score is a tool used to assess the severity of postoperative nausea and vomiting (PONV). This rating system uses a five-point scale ranging from 0 to 4. |
Postoperative 3 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours
|
|
40-item Quality of Recovery (QoR-40) score
기간: Postoperative 24 hours
|
The QoR-40 instrument is a tool used to assess a patient's quality of recovery after surgery. In this instrument, a higher score usually means better quality of recovery. |
Postoperative 24 hours
|
|
Pain-related measures
기간: 8.00 am on the morning after the operation
|
Post-operative venous blood samples were collected to measure serum markers, including C-reactive protein (CRP), interleukins (ILs, including IL-6 and IL-8) and cortisol. |
8.00 am on the morning after the operation
|
|
Safety indicators
기간: Postoperative 24 hours
|
Record the number of patients requiring additional analgesia, the total dose of medication administered, patients' post-operative vital signs, and any adverse events experienced by patients following use of the therapeutic device. |
Postoperative 24 hours
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .